Sweden-Russia experience exchange on lung cancer – accelerating innovation to improve survival and quality of life for people with lung cancer

Around 60 experts gathered during the virtual experience exchange between Sweden and Russia as part of a collaboration between the Association of Oncologists of Russia and Vision Zero cancer, aided by Business Sweden and the Embassy of Sweden to the Russian Federation.

A warm and shared welcome to the meeting was given by H.E. Malena Mård, Ambassador of Sweden to the Russian Federation, Mattias Lindgren, Swedish Trade Commissioner to the Russian Federation, Market Area Director Eurasia, Business Sweden, Professor Andrey Kaprin, MD, General Director of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, President of the Association of Oncologists of Russia, and Ebba Hallersjö Hult, Head of Vision Zero Cancer. The scene for Cancer care in Russia and Sweden with particular focus on lung cancer was set by presentations from Professor Andrey Ryabov, MD, Deputy General Director of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation and Associate Professor Mikael Johansson, MD, Senior Consultant Oncology, Umeå University Hospital and Senior lecturer at Umeå University.

The presentations and following discussions centred around three key areas containing an impressive 25 expert speakers giving their view on (1) Prevention, Improved awareness and Education, (2) Early Detection and Screening and(3) Diagnostics, Treatment and Care.

Attached to this short overview is the full agenda (link).

The meeting has further underbuilt the coming memorandum of cooperation (MoC) between the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation (NMRRC), the Association of Oncologists of Russia (AOR) and Vision Zero Cancer as well as paved way for experience exchanges on site in Sweden and Russia. All to continue the common fight against cancer.

Meeting agenda

The purpose of this meeting was to share knowledge and experience on how to improve early cancer diagnosis, outcomes and care for patients and to discuss potential new technologies for early lung cancer detection, including the implementation of targeted screening and precision diagnostics and treatment.